RUNX3 in oncogenic and anti-oncogenic signaling in gastrointestinal cancers

Journal of Cellular Biochemistry

Volumn 112, Issue 5, 2011, Pages 1243-1249

  Ito, Kosei ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

BMP; gastrointestinal cancers; RUNX3; TGF beta; Wnt

Indexed keywords

CANCER GROWTH FACTOR; TRANSCRIPTION FACTOR RUNX3; WNT PROTEIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROLIFERATION; COLON CANCER; DIGESTIVE SYSTEM CANCER; ENZYME ACTIVITY; HELICOBACTER INFECTION; HUMAN; INTESTINE EPITHELIUM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL ADHESION; CORE BINDING FACTOR ALPHA 3 SUBUNIT; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL MUCOSA; MICE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS; WNT PROTEINS;

HELICOBACTER PYLORI; PYRONIA TITHONUS;

EID: 79953689597     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23047     Document Type: Article

References (50)

1. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H,. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003-1007. (Pubitemid 350014593)
2. Barker N, Huch M, Kujala P, van de Wetering M, Snippert HJ, van Es JH, Sato T, Stange DE, Begthel H, van den Born M, Danenberg E, van den Brink S, Korving J, Abo A, Peters PJ, Wright N, Poulsom R, Clevers H,. 2010. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 6: 25-36.
3. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H,. 2002. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111: 251-263. (Pubitemid 35292445)
4. Beppu H, Mwizerwa ON, Beppu Y, Dattwyler MP, Lauwers GY, Bloch KD, Goldstein AM,. 2008. Stromal inactivation of BMPRII leads to colorectal epithelial overgrowth and polyp formation. Oncogene 27: 1063-1070. (Pubitemid 351253183)
5. Blyth K, Cameron ER, Neil JC,. 2005. The RUNX genes: Gain or loss of function in cancer. Nat Rev Cancer 5: 376-387. (Pubitemid 40637829)
6. Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, Woolf E, Groner Y,. 2004. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci USA 101: 16016-16021. (Pubitemid 39507919)
7. Chang TL, Ito K, Ko TK, Liu Q, Salto-Tellez M, Yeoh KG, Fukamachi H, Ito Y,. 2010. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterology 138: 255-265, e1-3.
8. Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC,. 2005. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 25: 8097-8107. (Pubitemid 41263003)
9. Chuang LS, Ito Y,. 2010. RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene 29: 2605-2615.
10. Clements WM, Wang J, Sarnaik A, Kim OJ, MacDonald J, Fenoglio-Preiser C, Groden J, Lowy AM,. 2002. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 62: 3503-3506. (Pubitemid 34651399)
11. Evans PM, Chen X, Zhang W, Liu C,. 2010. KLF4 interacts with beta-catenin/TCF4 and blocks p300/CBP recruitment by beta-catenin. Mol Cell Biol 30: 372-381.
12. -/- gastric epithelial cells differentiate into intestinal type cells. Biochem Biophys Res Commun 321: 58-64. (Pubitemid 39055605)
13. Furuse M, Tsukita S,. 2006. Claudins in occluding junctions of humans and flies. Trends Cell Biol 16: 181-188.
14. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR,. 2007. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132: 127-138. (Pubitemid 46108731)
15. Goh YM, Cinghu S, Hong ET, Lee YS, Kim JH, Jang JW, Li YH, Chi XZ, Lee KS, Wee H, Ito Y, Oh BC, Bae SC,. 2010. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. J Biol Chem 285: 10122-10129.
16. Guo WH, Weng LQ, Ito K, Chen LF, Nakanishi H, Tatematsu M, Ito Y,. 2002. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene 21: 8351-8355. (Pubitemid 35477876)
17. Hanai J, Chen LF, Kanno T, Ohtani-Fujita N, Kim WY, Guo WH, Imamura T, Ishidou Y, Fukuchi M, Shi MJ, Stavnezer J, Kawabata M, Miyazono K, Ito Y,. 1999. Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 274: 31577-31582.
18. Haramis AP, Begthel H, van den Born M, van Es J, Jonkheer S, Offerhaus GJ, Clevers H,. 2004. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 303: 1684-1686. (Pubitemid 38338329)
19. He XC, Zhang J, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li L,. 2004. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 36: 1117-1121. (Pubitemid 41184475)
20. Howe JR, Bair JL, Sayed MG, Anderson ME, Mitros FA, Petersen GM, Velculescu VE, Traverso G, Vogelstein B,. 2001. Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet 28: 184-187. (Pubitemid 32538067)
21. Ito Y, Miyazono K,. 2003. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 13: 43-47. (Pubitemid 36143926)
22. Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y,. 2005. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65: 7743-7750. (Pubitemid 41297249)
23. Ito K, Lim AC, Salto-Tellez M, Motoda L, Osato M, Chuang LS, Lee CW, Voon DC, Koo JK, Wang H, Fukamachi H, Ito Y,. 2008. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. Cancer Cell 14: 226-237.
24. Ito K, Inoue KI, Bae SC, Ito Y,. 2009. Runx3 expression in gastrointestinal tract epithelium: Resolving the controversy. Oncogene 28: 1379-1384.
25. Ito K, Chuang LS, Ito T, Chang TL, Fukamachi H, Salto-Tellez M, Ito Y,. 2011. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology DOI: 10.1053/j.gastro.2011.01.043.
26. Judd LM, Alderman BM, Howlett M, Shulkes A, Dow C, Moverley J, Grail D, Jenkins BJ, Ernst M, Giraud AS,. 2004. Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. Gastroenterology 126: 196-207. (Pubitemid 38040736)
27. Katz JP, Perreault N, Goldstein BG, Actman L, McNally SR, Silberg DG, Furth EE, Kaestner KH,. 2005. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 128: 935-945. (Pubitemid 40523545)
28. Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, Yang JO, Ito Y, Bae SC,. 2005. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res 65: 9347-9354. (Pubitemid 41508002)
29. Kitajima Y, Ohtaka K, Mitsuno M, Tanaka M, Sato S, Nakafusa Y, Miyazaki K,. 2008. Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol Rep 19: 197-202. (Pubitemid 351176149)
30. Lee CW, Ito K, Ito Y,. 2010. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer. Cancer Res 70: 4243-4252.
31. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y,. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124. (Pubitemid 34327521)
32. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T,. 2006. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-995. (Pubitemid 43259882)
33. Nam KT, Varro A, Coffey RJ, Goldenring JR,. 2007. Potentiation of oxyntic atrophy-induced gastric metaplasia in amphiregulin-deficient mice. Gastroenterology 132: 1804-1819. (Pubitemid 46677950)
34. Oshima M, Oshima H, Matsunaga A, Taketo MM,. 2005. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res 65: 9147-9151. (Pubitemid 41507975)
35. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M,. 2006. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 131: 1086-1095. (Pubitemid 44498691)
36. Peek RM, Jr., Blaser MJ,. 2002. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2: 28-37. (Pubitemid 37328805)
37. Quante M, Marrache F, Goldenring JR, Wang TC,. 2010. TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa. Gastroenterology 139: 2018-2027, e2.
38. Shi MJ, Stavnezer J,. 1998. CBF alpha3 (AML2) is induced by TGF-beta1 to bind and activate the mouse germline Ig alpha promoter. J Immunol 161: 6751-6760. (Pubitemid 28562218)
39. Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, Salto-Tellez M,. 2009. Molecular pathology of RUNX3 in human carcinogenesis. Biochim Biophys Acta Rev Cancer 1796: 315-331.
40. Tatematsu M, Tsukamoto T, Inada K,. 2003. Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94: 135-141. (Pubitemid 36575871)
41. Tomita H, Yamada Y, Oyama T, Hata K, Hirose Y, Hara A, Kunisada T, Sugiyama Y, Adachi Y, Linhart H, Mori H,. 2007. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway. Cancer Res 67: 4079-4087. (Pubitemid 46815052)
42. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP,. 1999. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96: 8681-8686. (Pubitemid 29354851)
43. Tsang YH, Lamb A, Romero-Gallo J, Huang B, Ito K, Peek RM, Jr., Ito Y, Chen LF,. 2010. Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 29: 5643-5650.
44. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl O, Fox JG, Wang TC,. 2008. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14: 408-419.
45. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H,. 2002. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250. (Pubitemid 35292444)
46. Weis VG, Goldenring JR,. 2009. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer 12: 189-197.
47. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, Koh H, Simms L, Barker M, Leggett B, Levine J, Kim M, French AJ, Thibodeau SN, Jass J, Haile R, Laird PW,. 2006. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793. (Pubitemid 43980599)
48. Yano T, Ito K, Fukamachi H, Chi XZ, Wee HJ, Inoue K, Ida H, Bouillet P, Strasser A, Bae SC, Ito Y,. 2006. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Mol Cell Biol 26: 4474-4488. (Pubitemid 43877568)
49. Yuasa Y,. 2003. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 3: 592-600. (Pubitemid 37328831)
50. Zhang Z, Wang S, Wang M, Tong N, Fu G,. 2008. Genetic variants in RUNX3 and risk of bladder cancer: A haplotype-based analysis. Carcinogenesis 29: 1973-1978.